167 related articles for article (PubMed ID: 21603803)
41. The intra-lesional variation of type, level of invasion, and tumour thickness of primary cutaneous malignant melanoma.
Søndergaard K
Acta Pathol Microbiol Scand A; 1980 Sep; 88(5):269-74. PubMed ID: 7468215
[TBL] [Abstract][Full Text] [Related]
42. Pathological assessment of tumor biopsy specimen and surgical sentinel lymph node dissection in patients with melanoma.
Nodiţi G; Nica CC; Petrescu HP; Ivan C; Crăiniceanu ZP; Bratu T; Dema A
Rom J Morphol Embryol; 2014; 55(3):915-8. PubMed ID: 25329120
[TBL] [Abstract][Full Text] [Related]
43. Clinical correlates of Breslow thickness of malignant melanoma.
Osborne JE; Hutchinson PE
Br J Dermatol; 2001 Mar; 144(3):476-83. PubMed ID: 11260002
[TBL] [Abstract][Full Text] [Related]
44. Epidemiological changes in cutaneous melanoma: retrospective study of 969 cases (1996-2010).
Avilés-Izquierdo JA; Lázaro-Ochaita P; Suárez-Fernández R; Márquez-Rodas I; Parra-Blanco V; Escat-Cortés JL
Rev Clin Esp (Barc); 2013 Mar; 213(2):81-7. PubMed ID: 22874464
[TBL] [Abstract][Full Text] [Related]
45. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil.
Borges SZ; Bakos L; Cartell A; Wagner M; Agostini A; Lersch E
Int J Dermatol; 2007 Jul; 46(7):679-86. PubMed ID: 17614794
[TBL] [Abstract][Full Text] [Related]
46. [Sentinel lymph node biopsy in patients with melanoma].
Tomás-Mallebrera L; Rojo-España R; Marquina-Vila A; Gimeno-Clemente N; Morales-Suárez-Varela MM
Actas Dermosifiliogr; 2010 Jun; 101(5):428-36. PubMed ID: 20525486
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
48. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
[TBL] [Abstract][Full Text] [Related]
49. Melanoma thickness: the role of patients' characteristics, risk indicators and patterns of diagnosis.
Haenssle HA; Hoffmann S; Holzkamp R; Samhaber K; Lockmann A; Fliesser M; Emmert S; Schön MP; Rosenberger A; Buhl T
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):102-8. PubMed ID: 24646029
[TBL] [Abstract][Full Text] [Related]
50. Patients' Characteristics, Histopathological Findings, and Tumor Stage in Different Types of Malignant Melanoma: A Retrospective Multicenter Study.
Farahmand AM; Ehsani AH; Mirzaei M; Mohsenian M; Ghanadan A
Acta Med Iran; 2017 May; 55(5):316-323. PubMed ID: 28724272
[TBL] [Abstract][Full Text] [Related]
51. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
Porto AC; Pinto Blumetti T; Oliveira Santos Filho IDA; Calsavara VF; Duprat Neto JP; Tavoloni Braga JC
PLoS One; 2020; 15(10):e0240864. PubMed ID: 33095773
[TBL] [Abstract][Full Text] [Related]
52. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service.
Ng JC; Swain S; Dowling JP; Wolfe R; Simpson P; Kelly JW
Arch Dermatol; 2010 Mar; 146(3):234-9. PubMed ID: 20231492
[TBL] [Abstract][Full Text] [Related]
53. University Hospital Waterford: 5-year experience of cutaneous melanoma.
Sehgal R; Cheung CX; Alradadi R; Healy DA; Landers R; O'Donoghue GT
Ir J Med Sci; 2017 May; 186(2):309-314. PubMed ID: 27873142
[TBL] [Abstract][Full Text] [Related]
54. Significance of vascular endothelial growth factor expression in skin melanoma.
Gajanin V; Krivokuća Z; Kostić K; Gajanin R; Sladojević I
Vojnosanit Pregl; 2010 Sep; 67(9):747-54. PubMed ID: 20949875
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.
Park CK; Kim SK
Oncotarget; 2017 Feb; 8(9):14759-14769. PubMed ID: 28107203
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.
Pizzichetta MA; Massi D; Mandalà M; Queirolo P; Stanganelli I; De Giorgi V; Ghigliotti G; Cavicchini S; Quaglino P; Corradin MT; Rubegni P; Alaibac M; Astorino S; Ayala F; Magi S; Mazzoni L; Manganoni MA; Talamini R; Serraino D; Palmieri G;
J Transl Med; 2017 Nov; 15(1):227. PubMed ID: 29115977
[TBL] [Abstract][Full Text] [Related]
57. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
58. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
[TBL] [Abstract][Full Text] [Related]
60. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
